QCM Cayman’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

QCM Cayman’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,428	Closed	-$333K	–	63
2022 Q2	$333K	Buy	+4,428	New	+$197K	5.76%	5

QCM Cayman's TPTX Position: Q3 2022 in Review

QCM Cayman sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 4,428 shares — an estimated $333K sold.

QCM Cayman first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $333K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

QCM Cayman reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
QCM Cayman sold 4,428 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $333K.
QCM Cayman first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
QCM Cayman's Turning Point Therapeutics, Inc. Common Stock position peaked at $333K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on QCM Cayman's 13F filing for Q3 2022, filed 10 Nov 2022.